Skip to main content
VCbacked
Log inGet Started

Bloomsbury Genetic Therapies

Cambridge, United Kingdom

Bloomsbury Genetic Therapies develops curative treatments for rare neurological and metabolic diseases using gene therapy technologies.

$5.6M raised
Oct 2022
Seed
BiopharmaBiotechnologyPharmaceutical

Top Investors

UCL Technology Fund

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Bloomsbury Genetic Therapies

How much funding has Bloomsbury Genetic Therapies raised?
Bloomsbury Genetic Therapies has raised $5.6M in total funding. The most recent round was Seed. The last funding was announced in October 2022.
Who are Bloomsbury Genetic Therapies's investors?
Bloomsbury Genetic Therapies's investors include UCL Technology Fund.
Where is Bloomsbury Genetic Therapies headquartered?
Bloomsbury Genetic Therapies is headquartered in Cambridge, United Kingdom.
What does Bloomsbury Genetic Therapies do?
Bloomsbury Genetic Therapies develops curative treatments for rare neurological and metabolic diseases using gene therapy technologies.
What stage is Bloomsbury Genetic Therapies at?
Bloomsbury Genetic Therapies is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Bloomsbury Genetic Therapies — Funding & Investors." VCBacked, October 6, 2022, https://www.vcbacked.co/company/bloomsbury-genetic-therapies. Accessed July 2, 2026.
APA
VCBacked. (2022). Bloomsbury Genetic Therapies — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/bloomsbury-genetic-therapies
Wikipedia (cite web)
{{cite web |title=Bloomsbury Genetic Therapies — Funding & Investors |url=https://www.vcbacked.co/company/bloomsbury-genetic-therapies |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
Allterum Therapeutics
Houston$1.0M
Epsilogen
London$16.3M
Cairn Therapeutics
Tucson$3.0M
Living In Silico Inc.
Brampton$3K
KuriBio
Berkeley$150K
Systemic Bio
Houston$15.0M